Publication | Closed Access

MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories

Mlh1 LossPathology LaboratoriesTumor HeterogeneityMedicineColorectal CancerPathologyCancer GenomicsMolecular PathologyHigh FrequencyCancer GeneticsMolecular DiagnosticsOncologyRadiation OncologyTumor BiologyHealth Sciences